Article info
Neurogastroenterology
Original research
Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS
- Correspondence to Professor Guy Boeckxstaens, Department of Chronic Diseases, Metabolism and Ageing, Center of Intestinal Neuro-Immune Interaction, Translational Research Center for Gastrointestinal Disorders (TARGID), KU Leuven, Leuven 3000, Belgium; guy.boeckxstaens{at}kuleuven.be
Citation
Effect of resolvins on sensitisation of TRPV1 and visceral hypersensitivity in IBS
Publication history
- Received April 22, 2020
- Revised September 11, 2020
- Accepted September 13, 2020
- First published October 6, 2020.
Online issue publication
January 10, 2022
Article Versions
- Previous version (9 January 2022).
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.